Skip to main content
CELC
NASDAQ Life Sciences

Celcuity Q3 Loss Narrower Than Expected as Launch Spending Runs $77.3M

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$64.04
Mkt Cap
$3.134B
52W Low
$53.54
52W High
$151.02
52W Position info
20% above low
Off High info
58% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CELC sits 20% above its 52-week low of $53.54.

Summary

Celcuity posted a Q3 adjusted loss of $1.21 per share, well inside the $1.43 IBES consensus, with adjusted net loss of $66.8 million versus an $82.2 million estimate. Reported net loss was $73.3 million and EPS -$1.33, with operating expenses at $77.3 million. The beat comes as the company funds the U.S. commercial rollout of REVTORPYK (gedatolisib), which became commercially available September 30 following the August sNDA filing in PIK3CA-mutant advanced breast cancer. The $754 million cash position disclosed with Q2 results gives runway into 2029, so this quarter's spend rate is the number to track against that guidance.

At the time of this announcement, CELC was trading at $64.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $53.54 to $151.02. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CELC - Latest Insights

CELC
Nov 09, 2026, 8:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $66.32
Real-time Price: $53.35 info
Change: -$12.97 (-20%) info
Market Cap: $2.621B info
CELC
Nov 05, 2026, 5:15 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $64.04
Real-time Price: $53.35 info
Change: -$10.69 (-17%) info
Market Cap: $2.621B info
CELC
Nov 05, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $64.04
Real-time Price: $53.35 info
Change: -$10.69 (-17%) info
Market Cap: $2.621B info
CELC
Sep 30, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.00
Real-time Price: $53.35 info
Change: -$25.65 (-32%) info
Market Cap: $2.621B info
CELC
Aug 26, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $91.00
Real-time Price: $53.35 info
Change: -$37.65 (-41%) info
Market Cap: $2.621B info